Skip to main content
. 2017 May 31;153(7):681–685. doi: 10.1001/jamadermatol.2017.1162

Figure 1. Cutaneous Response to Anti–Tumor Necrosis Factor α Agents.

Figure 1.

The overall cutaneous response rate was 24% (95% CI, 14%-40%) after 3 months, 46% (95% CI, 32%-62%) after 6 months, and 79% (95% CI, 64%-98%) after 12 months. Median ePOST severity score decreased from 5 at baseline to 3 at the last follow-up. Among a total of 31 responders, 13 achieved complete response and 18 achieved partial response as best response during follow-up.